BergstromJ., FurstP., ZimmermanL.: Uremic middle molecules exist and are biologically active.Clin. Neph.11: 229, 1979.
5.
BirkelandS.A.: Uremia as a state of immunodeficiency.Scand. J. Immun.20: 249, 1975.
6.
DobblesteinH., KornerW.F., MempelW., Grosse WildeH., EdelH.H.: Vit B6 deficiency in uremia and its implications for the depression of immune response.Kidney Int.5: 233, 1974.
GiangrandeA., CantùP., LimidoA., De FrancescoD., MalacridaV.: Continuous Ambulatory Peritoneal Dialysis and Cellular Immunity.Proc. EDTA19: 372, 1982.
9.
RoldsworthS.R., FitzgeraldM.G., HoskinC.S., AtkinsR.C.: The effect of maintenance dialysis on lymphocyte function.Clin. Exp. Immunol.33: 95, 1978.
10.
KasakuraS., LowensteinL.: The effect of uremic blood on mixed leukocyte reaction and on cultures of leukocytes with PHA.Transplantation2: 283, 1967.
11.
LamperiS., CarozziS., IcardiA., TrasforiniD.: Studi gelcromatografici in soggetti a funzionalità renale compromessa e integra.Atti dell'Incontro Hospal sul Poliacrilonitrile - AN69.S. Margherita di Pula, 1980, p. 229.
12.
LawD.K., DudrickS.J., AbdonM.I.: The effect of nutritional repletion.Ann. Int. Med.79: 545, 1973.
13.
MiyakoshiH., AokiT., HirasawaY.: Effects of serum and plasma from hemodialysis patients on the lymphoproliferative response.Clin. Neph.12: 263, 1979.
PiccoliG., GiacchinoF., BelardiP., QuarelloF., AloattiS., GiacchinoM., MussoA.: Immune response in peritoneal dialysis. In «Peritoneal Dialysis», Ed. La GrecaG., BiasioliS., RoncoC.; Wichtig Ed., Milano, 1982, pg. 479.
16.
ReddyM.M., GohK.O., CesteroR.V.M.: T and B lymphocytes in patients with chronic renal disease in hemodialysis.Experientia31: 980, 1975.
17.
RingoirS.M.G., Van LandschootN., De SmetR.: Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate.Clin. Neph.13: 109, 1980.
18.
SengarD.P.S., RashidA., PerelmutterL., HarrisJ.E.: Lymphocytotoxins and mixed leukocyte culture blocking factor activity in the plasma of uremic patients undergoing hemodialysis.Clin. Exp. Immun.20: 249, 1975.
19.
SinghS.: Lymphoblastic trasformation in patients changing from hemodialysis to CAPD.Kidney Int.21: 213, 1982.
20.
TouraineJ.L., TouraineF., RevillardJ.P., BrochierJ., TraegerJ.: T lymphocytes and serum inhibitors of cell-mediated immunity in renal insufficiency.Nephron14: 195, 1975.
21.
TraegerJ., TouraineJ.L., RevillardJ.P., BrochierJ., NavarroJ.: Role of methylguanidine and middle molecules in the immunodeficiency secondary to uremia.In Proc. 6th Int. Congr. Nephrol. Florence1975, pg. 584.
22.
TraegerJ.: Immunodeficiency in chronic renal insufficiency.Proc. EDTA17: 375, 1980.
23.
WallnerS.F., VautrinR.M.: The anemia in chronic renal failure.J. Lab. Clin. Med.92: 363, 1978.
24.
WybramJ., CarrM.C.: Rosette formation by human tymocytes.Cellular Immunity6: 362, 1973.